Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02121158 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly
A NA study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- NA
- Development phase
- 167
- Enrollment target
NCT02121158: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT02121158 is a NA study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 167 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02121158, a NA study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- NA
- Development phase
- 167 participants
- Enrollment target
Study Summary
The overall aim of this trial is to study the safety and efficacy of ICD implantation as a primary prevention strategy of sudden cardiac death in patients 70 years and older. This study will assess the many competing factors involved with ICD implantation including 1) the impact on mortality, especially in the context of a declining rate of sudden death with advanced age, 2) the tolerability of the powerful therapeutic action of the device, and 3) the impact on quality of life.
Interventions
- DEVICE Implantable Cardioverter Defibrillator
- OTHER Optimal Medical Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2015-08-07 |
| Est. Completion | 2020-11-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02121158
The ClinicalTrials.gov registry entry for NCT02121158 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Implantable Cardioverter Defibrillator is the first listed.
NCT02121158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02121158 about?
NCT02121158 is a clinical study titled "Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly". The overall aim of this trial is to study the safety and efficacy of ICD implantation as a primary prevention strategy of sudden cardiac death in patients 70 years and older. This study will assess the many competing factors involved with ICD implantation including 1) the impact on mortality, especi...
What is the current status of trial NCT02121158?
This trial is currently terminated. It is a NA study. The enrollment target is 167 participants. The study started on 2015-08-07. Estimated completion is 2020-11-06.
What interventions are being tested in trial NCT02121158?
The interventions under investigation include: Implantable Cardioverter Defibrillator (DEVICE), Optimal Medical Therapy (OTHER).
Who is sponsoring clinical trial NCT02121158?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.